Navigation Links
NanoLogix Inc. Files Multiple International Patent Applications for BioNanoChannel(TM) and Hydrogen Bioreactor Technology
Date:11/28/2007

Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of NanoLogix, Inc., and members of its management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

Contact:

Investor Relations

Bret Barnhizer, CEO

Telephone: 330-534-0800

E-mail: Bret@nanologixinc.com


'/>"/>
SOURCE NanoLogix, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Alvarado Hospital Files Countersuit Against Blue Shield
2. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
3. Pharsight Files Application for Nasdaq Capital Market Listing
4. Gentiva(R) Health Services Files Universal Shelf Registration Statement
5. Paramount Acquisition Corp. Files Amendment to Preliminary Proxy Statement for Proposed Acquisition of Chem Rx
6. CIGNA Behavioral Health Offers Members Online Provider Profiles
7. American Media Operations, Inc. Files Form 10-Q For First Quarter 2007
8. RxElite Files Registration Statement with Securities and Exchange Commission
9. Dynamic Files Articles of Merger; Notifies Nasdaq of Merger with GeoPharma
10. Mach One Corporation Files its Form SB-2 with the SEC
11. CryoCath files patent infringement lawsuit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...e/ -- Trust for America,s Health (TFAH) welcomed t... and Human Services (HHS) Tom Daschle before the S...nsions today and supports his goal to prioritize p...ified that the health care system must shift from ...stem, helping to prevent disease instead of treati...
(Date:1/8/2009)...ans Practice and St. Mary Medical Center have join...r staff more time to devote to patient care. This ...lp doctors in the Long Beach-Torrance area better ... managing a busy practice. Through this new allian...actice,s extensive resources to deliver essential ...
(Date:1/8/2009)... , Montreal, January 8, 2009 An internationa...ibution from a team led by Dr. John D. Rioux, a pr...d the Montreal Heart Institute, has identified gen...olitis. The findings, published in the advance onl...loser to understanding the biological pathways inv...
(Date:1/8/2009)...th & Science University,s School of Dentistry ( ww...of the peptide known as Nerve Growth Factor (NGF) ...igeminal nerve provides the signaling pathway for ...ssociated with temporomandibular disorder, trigemi... inflammatory conditions. , The study is posted ...
Breaking Medicine News(10 mins):Health News:Trust for America's Health Applauds Daschle's Commitment to Prevention 2Health News:Physicians Practice and St. Mary Medical Center Partner to Improve Patient Care in Long Beach, CA 2Health News:Physicians Practice and St. Mary Medical Center Partner to Improve Patient Care in Long Beach, CA 3Health News:Identification of genetic markers for ulcerative colitis could lead to treatment 2Health News:Identification of genetic markers for ulcerative colitis could lead to treatment 3
...VF) doctors in UK are demanding complete overhauli...ority (HFEA), following a judicial rap it has rec...he fertility regulator had unlawfully obtained war...a Panorama documentary. The Human Fertilisation a...
...y star Myleene Klass has followed in the footsteps...ant. The 29-year-old I'm A Celebrity star, weari...ce, posed naked for Glamour magazine's British edi..., 'Does my belly or my bum look big'. You just thi...
...J. Abdul Kalam Friday called for taking advantage ...c tool and of tele-radiology to help the needy in ...eaking during a visit to the digital radiology cen...dia Limited (ECIL), which is working towards provi...
... Gorakhpur District are grappling to fight against... that has killed at least 30 children in the past ...artment, B.R.D Medical College, said that the hosp... over 100 patients since January out of whom 30 ch...
Other Medicine News:Health News:UK Doctors Demand Overhauling of Fertility Regulatory Authority 2
(Date:12/27/2008)...FirstCall/ -- Warner Chilcott Limited (Nasdaq: W... and Mayne Pharma International Pty. Ltd. ("Mayne"...its against each of Mutual Pharmaceutical Company,...an") and Impax Laboratories, Inc. ("Impax") in th...r infringement of Mayne,s U.S. Patent No. 6,958,16...
(Date:12/17/2008)...alidation of non-animal alternative test methods ,...MatTek Corporation today announced that the ECVAM ...scientific validity of the Modified EpiDerm Skin I...C concluded that the Modified EpiDerm SIT has suff... of skin irritating and non-irritating test substa...
(Date:12/17/2008)...K Surgical, Inc., a medical,device company that h...on a,proprietary technology, announced today that...granted the company 510(k) clearance to market its...on of soft tissue during,plastic and reconstructi...opedic, arthroscopic, spinal and neurological surg...
(Date:12/17/2008)...ewswire-FirstCall/ -- NicOx,S.A. (NYSE Euronext P...pre-specified pooled analysis of 2,734 patients wi...pivotal phase 3 studies for naproxcinod. Both dose...n systolic and diastolic blood,pressure (SBP and ...e 13 week,period (p<0.001 for naproxcinod 750 ...
Breaking Medicine Technology:Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent 2Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent 3EpiDerm's Skin Irritation Test Fully Validated in European Union 2PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 2PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 3PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 4NicOx' Naproxcinod Shows Robust Blood Pressure Results in Phase 3 Pooled Analysis 2NicOx' Naproxcinod Shows Robust Blood Pressure Results in Phase 3 Pooled Analysis 3NicOx' Naproxcinod Shows Robust Blood Pressure Results in Phase 3 Pooled Analysis 4NicOx' Naproxcinod Shows Robust Blood Pressure Results in Phase 3 Pooled Analysis 5New Research Shows Dental Implants Require Significantly More Follow Up Treatment Than Root Canals 29768 1New Research Shows Dental Implants Require Significantly More Follow Up Treatment Than Root Canals 29768 2New Research Shows Dental Implants Require Significantly More Follow Up Treatment Than Root Canals 29768 3New Research Shows Dental Implants Require Significantly More Follow Up Treatment Than Root Canals 29768 4Dont Disturb Your Circadian Rhythm This Black Friday Sleep In Nap Later says Specialty Sleep Association 29766 1Dont Disturb Your Circadian Rhythm This Black Friday Sleep In Nap Later says Specialty Sleep Association 29766 2Wound Management Technologies Inc Announces FDA Clearance of 510k 29765 1Wound Management Technologies Inc Announces FDA Clearance of 510k 29765 2Wound Management Technologies Inc Announces FDA Clearance of 510k 29765 3Pharmaceutical Industry Needs to Speed Up Transformation to Meet Changing Market Dynamics According to Ernst 26 Young Report 29763 1Pharmaceutical Industry Needs to Speed Up Transformation to Meet Changing Market Dynamics According to Ernst 26 Young Report 29763 2Pharmaceutical Industry Needs to Speed Up Transformation to Meet Changing Market Dynamics According to Ernst 26 Young Report 29763 3Pharmaceutical Industry Needs to Speed Up Transformation to Meet Changing Market Dynamics According to Ernst 26 Young Report 29763 4
...007 - Pro-Pharmaceuticals,Inc. (Amex: PRW), a com...day updated the progress of its Phase II,clinical ...sectable,colorectal cancer patients who are unable...s Phase II clinical trial for first-line,treatment...dications may represent orphan drug status for DAV...
...ect Factor Xa Inhibitor,Shows a Significant Reduc...m Compared with Enoxaparin with Similarly Low Blee...Phase III clinical trial,data presented today at t...mostasis (ISTH) Congress demonstrate that once-dai...ficacy in the,prevention of venous thromboembolism...
Other Medicine Technology:Pro-Pharmaceuticals Updates Progress of Clinical Trials &,Davanat 505 (b)(2) Filings 2Pro-Pharmaceuticals Updates Progress of Clinical Trials &,Davanat 505 (b)(2) Filings 3Pro-Pharmaceuticals Updates Progress of Clinical Trials &,Davanat 505 (b)(2) Filings 4Pro-Pharmaceuticals Updates Progress of Clinical Trials &,Davanat 505 (b)(2) Filings 5Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 2Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 3Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 4Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 5
Duckbill. 3.5 mm tip. Light curve.
2 mm. Angled 13 degrees, 15 mm from angle to tip. Round handle.
2 mm curved tip. Round handle. Designated most popular model or size.
Large. Double-ended. 3 mm pointed end and 5 mm angled end.
Medicine Products: